BIOTECH MAJOR

摘要

On his 30th birthday last month, Vivek Ramaswamy had a lot to celebrate. Roivant Sciences, the company he founded last year to commercialize late-stage drugs for dementia-related illnesses, was still buzzing from the June IPO of its majority-owned subsidiary, Axovant Sciences.